The aminobarbituric acid-hydantoin rearrangement

Journal of Organic Chemistry

Volumn 68, Issue 12, 2003, Pages 4684-4692

  Meusel, Manuela ^a   Ambrozak, Agnieszka ^a   Hecker, Thomas K ^b   Gütschow, Michael ^a  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATION; AMINES; CATALYSIS; SYNTHESIS (CHEMICAL);

BROMINATION;

ORGANIC ACIDS;

1 BENZYL 5 ETHYLCARBAMOYL 5 METHYLHYDANTOIN; 1 BENZYL 5 METHYL 5 METHYLCARBAMOYLHYDANTOIN; 1 CYCLOHEXYL 5 ETHYLCARBAMOYL 5 METHYLHYDANTOIN; 1 CYCLOHEXYL 5 METHYL 5 METHYLCARBAMOYLHYDANTOIN; 1 ETHYL 5 ISOPROPYLAMINO 5 METHYLBARBITURIC ACID; 1 ETHYL 5 METHYL 5 PROPYLAMINOBARBITURIC ACID; 1 ETHYL 5 PHENYL 5 PROPYLAMINOBARBITURIC ACID; 1 ISOPROPYL 5 METHYL 5 METHYLCARBAMOYLHYDANTOIN; 1 METHYL 5 PHENYL 5 PROPYLAMINOBARBITURIC ACID; 1,5 DIMETHY 5 ISOPROPYLAMINOBARBITURIC ACID; 1,5 DIPHENYL 5 ISOPROPYLAMINOBARBITURIC ACID; 1,5 DIPHENYL 5 PROPYLAMINOBARBITURIC ACID; 5 AMINOBARBITURIC ACID DERIVATIVE; 5 BENZYLAMINO 1 ETHYL 5 METHYLBARBITURIC ACID; 5 BENZYLAMINO 1 ETHYL 5 PHENYLBARBITURIC ACID; 5 BENZYLAMINO 1 METHYL 5 PHENYLBARBITURIC ACID; 5 BENZYLAMINO 1,5 DIMETHYLBARBITURIC ACID; 5 BENZYLAMINO 1,5 DIPHENYLBARBITURIC ACID; 5 BENZYLAMINO 5 METHYL 1 PHENYLBARBITURIC ACID; 5 BENZYLAMINO 5 PHENYL 1 PROPYLBARBITURIC ACID; 5 CARBAMOYLHYDANTOIN; 5 CYCLOHEXYLAMINO 1 ETHYL 5 METHYLBARBITURIC ACID; 5 CYCLOHEXYLAMINO 1,5 DIMETHYLBARBITURIC ACID; 5 CYCLOHEXYLAMINO 5 METHYL 1 PHENYLBARBITURIC ACID; 5 ETHYLCARBAMOYL 1 ISOPROPYL 5 METHYLHYDANTOIN; 5 ETHYLCARBAMOYL 5 METHYL 1 PROPYLHYDANTOIN; AMINOBARBITURIC ACID; BARBITURIC ACID DERIVATIVE; HYDANTOIN; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ALKYLATION; ARTICLE; BROMINATION; CARBON NUCLEAR MAGNETIC RESONANCE; CHEMICAL REACTION; CHEMICAL STRUCTURE; PROTON NUCLEAR MAGNETIC RESONANCE; REACTION ANALYSIS; SYNTHESIS;

ALKYLATION; AMINES; BARBITURATES; CHROMATOGRAPHY, THIN LAYER; COMBINATORIAL CHEMISTRY TECHNIQUES; CYCLIZATION; HYDANTOINS; MAGNETIC RESONANCE SPECTROSCOPY; MOLECULAR STRUCTURE;

EID: 0037941262     PISSN: 00223263     EISSN: None     Source Type: Journal    
DOI: 10.1021/jo020761f     Document Type: Article

References (79)

1. López, C. A.; Trigo, G. G. Adv. Heterocycl. Chem. 1985, 38, 177-228.
2. Nefzi, A.; Giulianotti, M.; Truong, L.; Rattan, S.; Ostresh, J. M.; Houghten, R. A. J. Comb. Chem. 2002, 4, 175-178.
3. (a) Bazil, C. W.; Pedley, T. A. Annu. Rev. Med. 1998, 49, 135-162.
4. (b) Luer, M. S. Neurol. Res. 1998, 20, 178-182.
5. (a) Matsukura, M.; Daiku, Y.; Ueda, K.; Tanaka, S.; Igarashi, T.; Minami, N. Chem. Pharm. Bull. 1992, 40, 1823-1827.
6. (b) Knabe, J.; Baldauf, J.; Ahlhelm, A. Pharmazie 1997, 52, 912-919.
7. (a) Sarges, R.; Oates, P. J. Prog. Drug Res. 1993, 40, 99-159.
8. (b) Somsák, L.; Kovács, L.; Tóth, M.; Ösz, E.; Szilágyi, L.; Györgydeák, Z.; Dinya, Z.; Docsa, T.; Tóth, B.; Gergely, P. J. Med. Chem. 2001, 44, 2843-2848.
9. (a) Moloney, G. P.; Robertson, A. D.; Martin, G. R.; MacLennan, S.; Mathews, N.; Dodsworth, S.; Sang, P. Y.; Knight, C.; Glen, R. J. Med. Chem. 1997, 40, 2347-2362.
10. (b) Moloney, G. P.; Martin, G. R.; Mathews, N.; Milne, A.; Hobbs, H.; Dodsworth, S.; Sang, P. Y.; Knight, C.; Williams, M.; Maxwell, M.; Glen, R. C. J. Med. Chem. 1999, 42, 2504-2526.
11. (c) Byrtus, H.; Pawłowski, M.; Duszyńska, B.; Wesołowska, A.; Chojnacka-Wójcik, E.; Bojarski, A. J. Pol. J. Pharmacol. 2001, 53, 395-401.
12. (d) Stilz, H. U.; Jablonka, B.; Just, M.; Knolle, J.; Paulus, E. F.; Zoller, G. J. Med. Chem. 1996, 39, 2118-2122.
13. (e) Peyman, A.; Wehner, V.; Knolle, J.; Stilz, H. U.; Breipohl, G.; Scheunemann, K.-H.; Carniato, D.; Ruxer, J.-M.; Gourvest, J.-F.; Gadek, T. R.; Bodary, S. Bioorg. Med. Chem. Lett. 2000, 10, 179-182.
14. Last-Barney, K.; Davidson, W.; Cardozo, M.; Frye, L. L.; Grygon, C. A.; Hopkins, J. L.; Jeanfavre, D. D.; Pav, S.; Qian, C.; Stevenson, J. M.; Tong, L.; Zindell, R.; Kelly, T. A. J. Am. Chem. Soc. 2001, 123, 5643-5650.
15. (a) Renard, A.; Lhomme, J.; Kotera, M. J. Org. Chem. 2002, 67, 1302-1307.
16. (b) Walter, M. W. Nat. Prod. Rep. 2002, 19, 278-291.
17. (a) Jakše, R.; Krošelj, V.; Rec▲nik, S.; Soršak, G.; Svete, J.; Stanovnik, B.; Grdadolnik, S. G. Z. Naturforsch. 2002, 57b, 453-459.
18. (b) Chezal, J. M.; Delmas, G.; Mavel, S.; Elakmaoui, H.; Métin, J.; Diez, A.; Blache, Y.; Gueiffler, A.; Rubiralta, M.; Teulade, J. C.; Chavignon, O. J. Org. Chem. 1997, 62, 4085-4087.
19. (c) Guella, G.; Mancini, I.; Zibrowius, H.; Pietra, F. Helv. Chim. Acta 1988, 71, 773-782.
20. (a) Hanessian, S.; Yang, R.-Y. Tetrahedron Lett. 1996, 37, 5835-5838.
21. (b) Nefzi, A.; Ostresh, J. M.; Giulianotti, M.; Houghten, R. A. Tetrahedron Lett. 1998, 39, 8199-8202.
22. (c) Nefzi, A.; Dooley, C.; Ostresh, J. M.; Houghten, R. A. Bioorg. Med. Chem. Lett. 1998, 8, 2273-2278.
23. (a) DeWitt, S. H.; Kiely, J. S.; Stankovic, C. J.; Schroeder, M. C.; Cody, D. M. R.; Pavia, M. R. Proc. Natl. Acad. Sci. USA 1993, 90, 6909-6913.
24. (b) Boeijen, A.; Kruijtzer, J. A. W.; Liskamp, R. M. J. Bioorg. Med. Chem. Lett. 1998, 8, 2375-2380.
25. (c) Park, K.-H.; Kurth, M. J. Tetrahedron Lett. 2000, 41, 7409-7413.
26. Kim, S. W.; Ahn, S. Y.; Koh, J. S.; Lee, J. H.; Ro, S.; Cho, H. Y. Tetrahedron Lett. 1997, 38, 4603-4606.
27. Anteunis, M. J. O.; Spiessens, L.; De Witte, M.; Callens, R.; Reyniers, F. Bull. Soc. Chim. Belg. 1987, 96, 459-465.
28. (a) Schwenker, G.; Guo, H. Arch. Pharm. (Weinheim) 1993, 326, 45-50.
29. (b) Lehmann, J. Arch. Pharm. (Weinheim) 1984, 317, 459-465.
30. (c) Paul, S.; Gupta, M.; Gupta, R.; Loupy, A. Synthesis 2002, 75-78.
31. Sarges, R.; Howard, H. R.; Kelbaugh, P. R. J. Org. Chem. 1982, 47, 4081-4085.
32. Moskal, J.; Moskal, A. Synthesis 1979, 794-797.
33. (a) Moskal, J.; Moskal, A.; Milart, P. Tetrahedron Lett. 1982, 38, 1787-1792.
34. (b) Moskal, J.; Moskal, A.; Milart, P. Monatsh. Chem. 1984, 115, 187-195.
35. Lee, G.-Y.; Lee, Y.-S.; Koo, S. M.; Lee, K.-J. Bull. Korean Chem. Soc. 1999, 20, 1359-1362.
36. Beller, M.; Eckert, M.; Moradi, W. A.; Neumann, H. Angew. Chem., Int. Ed. 1999, 38, 1454-1457.
37. Hulme, C.; Ma, L.; Romano, J. J.; Morton, G.; Tang, S.-Y.; Cherrier, M.-P.; Choi, S.; Salvino, J.; Labaudiniere, R. Tetrahedron Lett. 2000, 42, 1889-1893.
38. Gütschow, M.; Hecker, T.; Eger, K. Synthesis 1999, 410-414.
39. Bartoń, H. J.; Matusik, L.; Bojarski, J. Pol. J. Chem. 1996, 70, 570-577.
40. Bojarski, J. T.; Mokrosz, J. L.; Bartoń, H. J.; Paluchowska, M. H. Adv. Heterocycl. Chem. 1985, 38, 229-297.
41. 13C NMR data of barbituric acids, see: (a) De Meester, P.; Jovanovic, M. V.; Chu, S. S. C.; Biehl, E. R. J. Heterocycl. Chem. 1986, 23, 337-341. (b) Cortes, S.; Kohn, H. J. Org. Chem. 1983, 48, 2246-2254.
42. 13C NMR data of barbituric acids, see: (a) De Meester, P.; Jovanovic, M. V.; Chu, S. S. C.; Biehl, E. R. J. Heterocycl. Chem. 1986, 23, 337-341. (b) Cortes, S.; Kohn, H. J. Org. Chem. 1983, 48, 2246-2254.
43. 7N). Relative intensities are noted in the Experimental Section.
44. +). Relative intensities are noted in the Experimental Section.
45. +). Relative intensities are noted in the Experimental Section.
46. 5). Relative intensities are noted in the Experimental Section.
47. 2NCO). Relative intensities are noted in the Experimental Section.
48. 6). Relative intensities are noted in the Experimental Section.
49. +). Relative intensities are noted in the Experimental Section.
50. 10). Relative intensities are noted in the Experimental Section.
51. 6). Relative intensities are noted in the Experimental Section.
52. This has also been reported for a few 5-carbamoylhydantoins known so far: Zanotti, G.; Pinnen, F. J. Heterocycl. Chem. 1981, 18, 1629-1633. See also refs 16, 17, 21.
53. (a) de Faubert Maunder, M. J. Analyst 1975, 100, 878-883.
54. (b) Bult, A. Pharm. Weekbl, 1975, 110, 1161-1163.
55. N-Substituted compounds 8 and 9 failed to react with cobalt-(II) nitrate, too.
56. (a) van der Plas, H. C. Acc. Chem. Res. 1978, 11, 462-468.
57. (b) Maiboroda, D. A.; Babaev, E. V.; Jug, K. J. Org. Chem. 1997, 62, 7100-7105.
58. Garrett, E. R.; Bojarski, J. T.; Yakatan, G. J. J. Pharm. Sci. 1971, 60, 1145-1154.
59. Williams, A.; Douglas, K. T. Chem. Rev. 1975, 75, 627-649.
60. Hegarty, A. F.; Hegarty, C. N.; Scott, F. L. J. Chem. Soc., Perkin Trans. 2 1974, 1258-1268.
61. Gütschow, M. J. Org. Chem. 1999, 64, 5109-5115.
62. Intermediate acylisocyanates were generated by phosgenation of the carboxamide moiety of cyclic imines and underwent a trapping reaction to fused hydantoin iminium chlorides: Jaunin, R.; Arnold, W. Helv. Chim. Acta 1973, 56, 2569-2583. For further examples to prepare fused imidazo derivatives by trapping reactions, see ref 43.
63. Gütschow, M.; Powers, J. C. J. Org. Chem. 2001, 66, 4723-4727.
64. Mukaiyama, T.; Tokizawa, M.; Nohira, H.; Takei, H. J. Org. Chem. 1961, 26, 4381-4384.
65. Matoba, K.; Ishigami, E.; Takahata, H.; Yamasaki, T. Chem. Pharm. Bull. 1981, 29, 651-656.
66. Guest, A. W.; Milner, P. H. Tetrahedron Lett. 1984, 25, 4845-4848.
67. Clarke-Lewis, J. W.; Moody, K. Aust. J. Chem. 1970, 23, 1229-1248.
68. Keys, L. D., III; Folting, K.; Streib, W. E.; Johnston, M. J. Org. Chem. 1986, 51, 4721-4723.
69. (a) Senda, S.; Hirota, K.; Banno, K. Tetrahedron Lett. 1974, 35, 3087-3088.
70. (b) Sayer, J. M.; DePecol, M. J. Am. Chem. Soc. 1977, 99, 2665-2671.
71. (c) Otter, B. A.; Sasson, I. M.; Gagnier, R. P. J. Org. Chem. 1982, 47, 508-513.
72. (a) Senda, S.; Izumi, H.; Fujimura, H. Drug Res. 1967, 17, 1519-1523.
73. (b) Knabe, J.; Schmitt, W. Arch. Pharm. (Weinheim) 1984, 317, 789-796.
74. (c) Lapachev, V. V.; Stadlbauer, W.; Kappe, T. Monatsh. Chem. 1988, 119, 97-102.
75. Tóth, G.; Makleit, S. Acta Chim. Acad. Sci. Hung. 1981, 107, 139-145.
76. Knabe, J.; Reinhardt, J. Arch. Pharm. (Weinheim) 1982, 315, 706-716.
77. Aspelund, H. Acta Acad. Abo. Ser. B 1939, XII, 5, 1-33.
78. Saettone, M. F. J. Org. Chem. 1966, 31, 1959-1962.
79. Mixtures of N-3 and N-1 alkylation products have also been obtained, see ref 13.